Mount Sinai has a unique and rich tradition of specialized and individualized treatment and scientific research and discovery in ulcerative colitis. The physicians/scientists in the Mount Sinai Health System are constantly conducting clinical trials and are developing new drug therapies to help patients manage their disease.
Ulcerative colitis, a type of IBD, causes inflammation in the large intestine or colon and the lining of the colon becomes inflamed and develops tiny open sores, or ulcers, that produce pus and mucous. It can cause a variety of symptoms—including chronic diarrhea that may or may not go into periods of remission, mild to severe abdominal pain, fatigue, and malnutrition— and can have a major impact on quality of life. While the cause of IBD is still unknown, it involves the interplay of genetic predisposition, an abnormal immune system response, and environmental factors.
Below are some symptoms:
- Persistent diarrhea and rectal bleeding
- Urgent need to move bowels
- Abdominal cramping and pain
- Constipation Fever
- Appetite and Weight Loss
- Night sweats
- Loss of normal menstrual cycle
Please note: only proper testing performed by your doctor can diagnose ulcerative colitis.